BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19642738)

  • 1. Lobular neoplasia of the breast: an update.
    Contreras A; Sattar H
    Arch Pathol Lab Med; 2009 Jul; 133(7):1116-20. PubMed ID: 19642738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
    Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
    Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
    Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
    Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
    J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
    Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
    Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular Neoplasia.
    Lunt L; Coogan A; Perez CB
    Surg Clin North Am; 2022 Dec; 102(6):947-963. PubMed ID: 36335930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
    Dabbs DJ; Bhargava R; Chivukula M
    Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast.
    de Deus Moura R; Wludarski SC; Carvalho FM; Bacchi CE
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):1-12. PubMed ID: 22595945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
    De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
    Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
    Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
    Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular neoplasia.
    King TA; Reis-Filho JS
    Surg Oncol Clin N Am; 2014 Jul; 23(3):487-503. PubMed ID: 24882347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
    Crisi GM; Mandavilli S; Cronin E; Ricci A
    Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
    Chen YY; Hwang ES; Roy R; DeVries S; Anderson J; Wa C; Fitzgibbons PL; Jacobs TW; MacGrogan G; Peterse H; Vincent-Salomon A; Tokuyasu T; Schnitt SJ; Waldman FM
    Am J Surg Pathol; 2009 Nov; 33(11):1683-94. PubMed ID: 19701073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
    Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
    Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-operative breast pathology: lobular neoplasia.
    Reis-Filho JS; Pinder SE
    J Clin Pathol; 2007 Dec; 60(12):1321-7. PubMed ID: 17182661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
    Choi YJ; Pinto MM; Hao L; Riba AK
    Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
    Canas-Marques R; Schnitt SJ
    Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
    Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.